Après-demain SA is a Swiss conglomerate focused on three main activities:
1. **Life Science**: The Life Science division, Debiopharm, develops and markets medicines for the treatment of cancer and bacterial infections.
2. **Responsible Capital Management**: The Capital Management division invests in various asset classes, such as Private Equity, Private Debt, and listed equities, to create long-term value. It also supports companies in various sectors, including real estate, renewable energy, and education.
3. **Philanthropy**: The company's philanthropic division supports various social and environmental projects, such as securing water resources and promoting education.
Overall, the company focuses on creating long-term value and promoting sustainable growth in various areas.